Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1614 1628
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19417018 | SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY | Non-Final OA | Allergan, Inc. |
| 18317725 | METHODS OF TREATING HEAVY MENSTRUAL BLEEDING | Non-Final OA | AbbVie Inc. |
| 17325900 | METHODS OF TREATING HEAVY MENSTRUAL BLEEDING | Non-Final OA | AbbVie Inc. |
| 17242755 | COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-INTENSIVE CARE COGNITIVE DYSFUNCTION AND COGNITIVE DYSFUNCTION RESULTING FROM RESPIRATORY DISTRESS | Non-Final OA | Abrexa Pharmaceuticals, Inc. |
| 18853643 | Indolium Compounds for Treating Cancer | Non-Final OA | Emory University |
| 17596779 | COMPOSITIONS AND METHODS USING THYMOL AND/OR CARVACROL FOR INDUCTION OF AUTOPHAGY | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18294823 | METHODS OF TREATING MIGRAINE WITH MNK INHIBITORS | Non-Final OA | Board of Regents, The University of Texas System |
| 17329742 | COSMETIC COMPOSITION COMPRISING VITAMIN C | Non-Final OA | L'OREAL |
| 18683535 | FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18759232 | Treatment of Pneumonia | Final Rejection | COMBIOXIN SA |
| 18456718 | IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | Final Rejection | Arvinas Operations, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy